• Je něco špatně v tomto záznamu ?

Role of antibiotic prophylaxis in antenatal hydronephrosis: A systematic review from the European Association of Urology/European Society for Paediatric Urology Guidelines Panel

MS. Silay, S. Undre, AK. Nambiar, HS. Dogan, R. Kocvara, RJM. Nijman, R. Stein, S. Tekgul, C. Radmayr,

. 2017 ; 13 (3) : 306-315. [pub] 20170319

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc18025057

BACKGROUND: The benefits and harms of continuous antibiotic prophylaxis (CAP) versus observation in patients with antenatal hydronephrosis (ANH) are controversial. OBJECTIVE: The aim was to determine the effectiveness of CAP for ANH, and if beneficial to determine the best type and regimen of antibiotic and the most harmful to provide guidance for clinical practice. METHODS: A systematic literature search was performed in databases including Medline, Embase, and Cochrane in June 2015. The protocol was prospectively registered to PROSPERO (CRD42015024775). The search started from 1980, when maternal ultrasound was first introduced into clinical practice. Eligible studies were critically evaluated for risk of bias using Revman software. The outcomes included reduction in urinary tract infections (UTI), drug-related adverse events and kidney functions. RESULTS: Of 797 articles identified, 57 full text articles and six abstracts were eligible for inclusion (2 randomized controlled trials, 11 non-randomized comparative studies, and 50 case series). It remains unclear whether CAP is superior to observation in decreasing UTIs. No conclusion could be drawn for drug-related adverse events and kidney function because of lack of data. Children who were not circumcised, with ureteral dilatation, and high-grade hydronephrosis may be more likely to develop UTI, and CAP may be warranted for these subgroups of patients. A majority of the studies had low-to-moderate quality of evidence and with high risk of bias. CONCLUSIONS: The benefits of CAP in a heterogeneous group of children with ANH involving different etiologies remains unproven. However, the evidence in the form of prospective and retrospective observational studies has shown that it reduces febrile UTI in particular subgroups.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18025057
003      
CZ-PrNML
005      
20180716123247.0
007      
ta
008      
180709s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jpurol.2017.02.023 $2 doi
035    __
$a (PubMed)28462806
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Silay, Mesrur Selcuk $u Division of Pediatric Urology, Department of Urology, Istanbul Medeniyet University, Istanbul, Turkey. Electronic address: selcuksilay@gmail.com.
245    10
$a Role of antibiotic prophylaxis in antenatal hydronephrosis: A systematic review from the European Association of Urology/European Society for Paediatric Urology Guidelines Panel / $c MS. Silay, S. Undre, AK. Nambiar, HS. Dogan, R. Kocvara, RJM. Nijman, R. Stein, S. Tekgul, C. Radmayr,
520    9_
$a BACKGROUND: The benefits and harms of continuous antibiotic prophylaxis (CAP) versus observation in patients with antenatal hydronephrosis (ANH) are controversial. OBJECTIVE: The aim was to determine the effectiveness of CAP for ANH, and if beneficial to determine the best type and regimen of antibiotic and the most harmful to provide guidance for clinical practice. METHODS: A systematic literature search was performed in databases including Medline, Embase, and Cochrane in June 2015. The protocol was prospectively registered to PROSPERO (CRD42015024775). The search started from 1980, when maternal ultrasound was first introduced into clinical practice. Eligible studies were critically evaluated for risk of bias using Revman software. The outcomes included reduction in urinary tract infections (UTI), drug-related adverse events and kidney functions. RESULTS: Of 797 articles identified, 57 full text articles and six abstracts were eligible for inclusion (2 randomized controlled trials, 11 non-randomized comparative studies, and 50 case series). It remains unclear whether CAP is superior to observation in decreasing UTIs. No conclusion could be drawn for drug-related adverse events and kidney function because of lack of data. Children who were not circumcised, with ureteral dilatation, and high-grade hydronephrosis may be more likely to develop UTI, and CAP may be warranted for these subgroups of patients. A majority of the studies had low-to-moderate quality of evidence and with high risk of bias. CONCLUSIONS: The benefits of CAP in a heterogeneous group of children with ANH involving different etiologies remains unproven. However, the evidence in the form of prospective and retrospective observational studies has shown that it reduces febrile UTI in particular subgroups.
650    12
$a antibiotická profylaxe $7 D019072
650    _2
$a lidé $7 D006801
650    _2
$a hydronefróza $x komplikace $7 D006869
650    _2
$a novorozenec $7 D007231
650    _2
$a infekce močového ústrojí $x etiologie $x prevence a kontrola $7 D014552
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Undre, Shabnam $u Department of Pediatric and Adult Urology, East and North Herts NHS Trust, Stevenage, UK.
700    1_
$a Nambiar, Arjun K $u Department of Urology, Freeman Hospital, Newcastle upon Tyne, UK.
700    1_
$a Dogan, Hasan Serkan $u Division of Pediatric Urology, Department of Urology, Hacettepe University, Ankara, Turkey.
700    1_
$a Kocvara, Radim $u Department of Urology, General Teaching Hospital and Charles University, 1st Faculty of Medicine in Praha, Prague, Czechia.
700    1_
$a Nijman, Rien J M $u Department of Urology and Pediatric Urology, University Medical Centre Groningen, The Netherlands.
700    1_
$a Stein, Raimund $u Department of Urology, University of Mainz, Germany.
700    1_
$a Tekgul, Serdar $u Division of Pediatric Urology, Department of Urology, Hacettepe University, Ankara, Turkey.
700    1_
$a Radmayr, Christian $u Department of Urology, Medical University of Innsbruck, Austria.
773    0_
$w MED00166989 $t Journal of pediatric urology $x 1873-4898 $g Roč. 13, č. 3 (2017), s. 306-315
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28462806 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180709 $b ABA008
991    __
$a 20180716123545 $b ABA008
999    __
$a ok $b bmc $g 1317188 $s 1021978
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 13 $c 3 $d 306-315 $e 20170319 $i 1873-4898 $m Journal of pediatric urology $n J Pediatr Urol $x MED00166989
LZP    __
$a Pubmed-20180709

Najít záznam

Citační ukazatele

Možnosti archivace